The role of procoagulants and anticoagulants in the development of venous thromboembolism
- PMID: 19303503
- DOI: 10.1016/S0049-3848(09)70142-2
The role of procoagulants and anticoagulants in the development of venous thromboembolism
Abstract
Procoagulant and anticoagulant reactions play an important role in the regulation of thrombin formation during secondary hemostasis. Three phases can be recognized in the kinetics of thrombin formation: an initiation phase, a propagation phase and a termination phase. Dysregulation of thrombin formation during each of these phases by (hereditary) changes in the plasma concentration of pro- and anticoagulants contributes to the development of venous thrombosis. Most important seems the defective down-regulation of the prothrombinase activity during the termination phase. Procoagulant and anticoagulant proteins have important roles in the regulation of fibrin formation during secondary hemostasis. Under normal physiological conditions there is a delicate balance between the procoagulant and anticoagulant reactions. After damage to the vessel wall sufficient fibrin is formed to arrest bleeding and allow repair of the lesion without obstructing blood circulation. Venous thrombosis can be considered as a hemostatic process getting out of control, where massive fibrin formation has resulted in the formation of an obstructive thrombus. Such thrombus formation is believed to be facilitated by changes in the vessel wall, blood flow and the composition of the blood. During the past 50 years substantial progress has been made in our understanding of the enzymatic reactions involved in the hemostatic process. At the same time information has been obtained on particular changes in the composition of the blood which contribute to the development of venous thrombosis. Most of these changes concern the procoagulant and anticoagulant systems. In this paper I will briefly discuss how fibrin formation is regulated by procoagulant and anticoagulant reactions and how certain changes in these pathways contribute to the development of venous thrombosis.
Similar articles
-
Standardization and clinical utility of thrombin-generation assays.Semin Thromb Hemost. 2008 Oct;34(7):670-82. doi: 10.1055/s-0028-1104546. Epub 2008 Dec 15. Semin Thromb Hemost. 2008. PMID: 19085768 Review.
-
Thrombin elaboration in endotoxin-induced intravascular fibrin deposition. A leukocyte dependent process distinct from systemic hypercoagulability.Thromb Haemost. 1976 Dec 31;36(3):615-22. Thromb Haemost. 1976. PMID: 1037155
-
Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.J Intern Med. 2005 Mar;257(3):209-23. doi: 10.1111/j.1365-2796.2004.01444.x. J Intern Med. 2005. PMID: 15715678 Review.
-
Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.Microcirculation. 2008 May;15(4):269-82. doi: 10.1080/10739680701653517. Microcirculation. 2008. PMID: 18464157
-
The endogenous thrombin potential and the risk of venous thromboembolism.Thromb Res. 2007;121(3):353-9. doi: 10.1016/j.thromres.2007.04.012. Epub 2007 Jun 8. Thromb Res. 2007. PMID: 17560633
Cited by
-
Indoor nanoscale particulate matter-induced coagulation abnormality based on a human 3D microvascular model on a microfluidic chip.J Nanobiotechnology. 2019 Feb 1;17(1):20. doi: 10.1186/s12951-019-0458-2. J Nanobiotechnology. 2019. PMID: 30709410 Free PMC article.
-
Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.Eur J Clin Pharmacol. 2012 Jun;68(6):923-35. doi: 10.1007/s00228-011-1209-y. Eur J Clin Pharmacol. 2012. PMID: 22286157
-
The influence of corn trypsin inhibitor on the contribution of coagulation determinants to the Technoclone Thrombin Generation Assay (TGA) and the Calibrated Automated Thrombogram (CAT).PLoS One. 2022 Feb 25;17(2):e0263960. doi: 10.1371/journal.pone.0263960. eCollection 2022. PLoS One. 2022. PMID: 35213588 Free PMC article.
-
Antiplatelet effects of qishen yiqi dropping pill in platelets aggregation in hyperlipidemic rabbits.Evid Based Complement Alternat Med. 2012;2012:205451. doi: 10.1155/2012/205451. Epub 2012 Aug 27. Evid Based Complement Alternat Med. 2012. PMID: 22969824 Free PMC article.
-
Pathogenesis of thrombosis: cellular and pharmacogenetic contributions.Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S291-S298. doi: 10.21037/cdt.2017.09.11. Cardiovasc Diagn Ther. 2017. PMID: 29399533 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous